08.12.24 -- Working With EMA/FDA To Develop Hemgenix Potency Assays

In continuing from Part 1 of our series, we delve deeper into the crucial elements of transparency that prospective clients should consider when partnering with a CDMO.

By providing essential components like nucleases, gRNAs, and HDR templates, a reliable CDMO facilitates a seamless transition from discovery research to clinical trials and beyond.

To find the plasmid manufacturer with the appropriate knowledge and experience to manufacture your plasmid with quality and efficiency, you’ll need to recognize the offerings of a seasoned supplier.

Gain insight on how to achieve a 2000L scale-up by observing studies optimized through process characterization and other experimental approaches to better understand key process steps.

Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.

Extracellular vesicles hold immense potential for treating diseases, owing to their natural biocompatibility and ability to carry a diverse arsenal of therapeutic molecules.

Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.